December 27, 2024 - 05:01
Joerg Hurlin, Managing Director with AAT, recently discussed a pioneering advancement in the egg industry: in-ovo sexing technology. This innovative system allows for the determination of an embryo's sex while still in the egg, a significant breakthrough that could reshape poultry farming practices. Traditionally, determining the sex of chicks has been a labor-intensive process, often resulting in the culling of male chicks shortly after hatching.
With this new technology, farmers can identify the sex of an embryo at an early stage, enabling them to make informed decisions about which eggs to incubate. This advancement not only enhances animal welfare by reducing the number of male chicks that are euthanized but also promises to improve the economic efficiency of egg production.
As the first of its kind in the United States, this in-ovo sexing technology is expected to have far-reaching implications for the poultry industry, promoting sustainable practices and aligning with growing consumer demand for ethical farming methods.
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...